Cargando…

Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities

Tanshinones are a class of abietane diterpene compound isolated from Salvia miltiorrhiza (Danshen or Tanshen in Chinese), a well-known herb in Traditional Chinese Medicine (TCM). Since they were first identified in the 1930s, more than 40 lipophilic tanshinones and structurally related compounds hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yong, Jiang, Peixin, Ye, Min, Kim, Sung-Hoon, Jiang, Cheng, Lü, Junxuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497345/
https://www.ncbi.nlm.nih.gov/pubmed/23202971
http://dx.doi.org/10.3390/ijms131013621
_version_ 1782249742836695040
author Zhang, Yong
Jiang, Peixin
Ye, Min
Kim, Sung-Hoon
Jiang, Cheng
Lü, Junxuan
author_facet Zhang, Yong
Jiang, Peixin
Ye, Min
Kim, Sung-Hoon
Jiang, Cheng
Lü, Junxuan
author_sort Zhang, Yong
collection PubMed
description Tanshinones are a class of abietane diterpene compound isolated from Salvia miltiorrhiza (Danshen or Tanshen in Chinese), a well-known herb in Traditional Chinese Medicine (TCM). Since they were first identified in the 1930s, more than 40 lipophilic tanshinones and structurally related compounds have been isolated from Danshen. In recent decades, numerous studies have been conducted to investigate the isolation, identification, synthesis and pharmacology of tanshinones. In addition to the well-studied cardiovascular activities, tanshinones have been investigated more recently for their anti-cancer activities in vitro and in vivo. In this review, we update the herbal and alternative sources of tanshinones, and the pharmacokinetics of selected tanshinones. We discuss anti-cancer properties and identify critical issues for future research. Whereas previous studies have suggested anti-cancer potential of tanshinones affecting multiple cellular processes and molecular targets in cell culture models, data from in vivo potency assessment experiments in preclinical models vary greatly due to lack of uniformity of solvent vehicles and routes of administration. Chemical modifications and novel formulations had been made to address the poor oral bioavailability of tanshinones. So far, human clinical trials have been far from ideal in their design and execution for the purpose of supporting an anti-cancer indication of tanshinones.
format Online
Article
Text
id pubmed-3497345
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-34973452012-11-29 Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities Zhang, Yong Jiang, Peixin Ye, Min Kim, Sung-Hoon Jiang, Cheng Lü, Junxuan Int J Mol Sci Review Tanshinones are a class of abietane diterpene compound isolated from Salvia miltiorrhiza (Danshen or Tanshen in Chinese), a well-known herb in Traditional Chinese Medicine (TCM). Since they were first identified in the 1930s, more than 40 lipophilic tanshinones and structurally related compounds have been isolated from Danshen. In recent decades, numerous studies have been conducted to investigate the isolation, identification, synthesis and pharmacology of tanshinones. In addition to the well-studied cardiovascular activities, tanshinones have been investigated more recently for their anti-cancer activities in vitro and in vivo. In this review, we update the herbal and alternative sources of tanshinones, and the pharmacokinetics of selected tanshinones. We discuss anti-cancer properties and identify critical issues for future research. Whereas previous studies have suggested anti-cancer potential of tanshinones affecting multiple cellular processes and molecular targets in cell culture models, data from in vivo potency assessment experiments in preclinical models vary greatly due to lack of uniformity of solvent vehicles and routes of administration. Chemical modifications and novel formulations had been made to address the poor oral bioavailability of tanshinones. So far, human clinical trials have been far from ideal in their design and execution for the purpose of supporting an anti-cancer indication of tanshinones. Molecular Diversity Preservation International (MDPI) 2012-10-22 /pmc/articles/PMC3497345/ /pubmed/23202971 http://dx.doi.org/10.3390/ijms131013621 Text en © 2012 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0).
spellingShingle Review
Zhang, Yong
Jiang, Peixin
Ye, Min
Kim, Sung-Hoon
Jiang, Cheng
Lü, Junxuan
Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
title Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
title_full Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
title_fullStr Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
title_full_unstemmed Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
title_short Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
title_sort tanshinones: sources, pharmacokinetics and anti-cancer activities
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497345/
https://www.ncbi.nlm.nih.gov/pubmed/23202971
http://dx.doi.org/10.3390/ijms131013621
work_keys_str_mv AT zhangyong tanshinonessourcespharmacokineticsandanticanceractivities
AT jiangpeixin tanshinonessourcespharmacokineticsandanticanceractivities
AT yemin tanshinonessourcespharmacokineticsandanticanceractivities
AT kimsunghoon tanshinonessourcespharmacokineticsandanticanceractivities
AT jiangcheng tanshinonessourcespharmacokineticsandanticanceractivities
AT lujunxuan tanshinonessourcespharmacokineticsandanticanceractivities